Global Antimicrobial Resistance Innovation Fund-(GAMRIF)
Global Antimicrobial Resistance Innovation Fund-(GAMRIF)
Explore linked clinical trials.2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults | Healthy Participants | Recruiting | Phase 1 | 2026-09-22 | NCT07035769 | |
| A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections | Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Surgical Wound Infection, Wound Infection | Recruiting | Phase 1 | 2026-08-17 | NCT07379684 |